View More Recent Stories

Oct 31, 2024 07:05AM Insmed (INSM) Misses Q3 EPS by 7c ; Offers Guidance
Oct 11, 2024 06:03AM Insmed (INSM) PT Raised to $100 at Truist Securities
Oct 9, 2024 07:52AM TD Cowen Reiterates Buy Rating on Insmed (INSM)
Oct 8, 2024 04:06PM Insmed (INSM): New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results
Sep 24, 2024 11:22AM Insmed (INSM) option IV flat amid wide 2024 price movement
Sep 10, 2024 12:00PM Stifel Reiterates Buy Rating on Insmed (INSM)
Sep 3, 2024 05:41AM Goldman Adjusts Monthly US Directors Cut Conviction List
Aug 29, 2024 08:14AM H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
Aug 15, 2024 06:42AM Insmed (INSM) PT Raised to $92 at Mizuho, 'continue to favor it as our top longer-term idea'
Aug 9, 2024 10:46AM Insmed (INSM) PT Raised to $98 at TD Cowen
Aug 8, 2024 07:15AM Insmed (INSM) Misses Q2 EPS by 70c ; Offers Guidance
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 9, 2024 07:00PM 2Q24 U.S. biotech earnings preview
Jul 8, 2024 10:53AM Mizuho Reiterates Outperform Rating on Insmed (INSM)
Jul 5, 2024 07:53AM TD Cowen Reiterates Buy Rating on Insmed (INSM)
Jul 2, 2024 06:38AM H.C. Wainwright Reiterates Buy Rating on Insmed (INSM)
Jul 1, 2024 05:58AM Insmed (INSM) PT Raised to $88 at Truist Securities
Jun 27, 2024 08:03AM Insmed (INSM) Redeems $225M of Notes
Jun 25, 2024 02:52PM Insmed (INSM) PT Raised to $90 at Barclays
Jun 21, 2024 06:01AM Insmed (INSM) PT Raised to $75 at Evercore ISI
Apr 5, 2024 07:00PM These stocks are Wells Fargo's 14 high-conviction ideas for Q2
View More Recent Stories